Example: Heart Attack

Search clinical trials for: Alendronate

Total 181 results

NCT01133496

Completed

Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions

Conditions: Healthy
NCT02371252

Unknown status

Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment

Conditions: Osteoporosis
NCT00920075

Completed

Alendronate in Juvenile Osteoporosis

Conditions: Juvenile Osteoporosis; Low Bone Density; Fractures
NCT00359385

Withdrawn

The Effects of Alendronate After Cure of Primary Hyperparathyroidism

Conditions: Hyperparathyroidism
NCT02461667

Completed

Alendronate Compared to Metformin in Chronic Periodontitis

Conditions: Chronic Periodontitis
NCT00460057

Completed

The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss

Conditions: Osteoporosis
NCT00504166

Completed

Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women

Conditions: Osteopenia; Osteoporosis
NCT00936260

Completed

Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis

Conditions: Osteoporosis
NCT00259857

Completed

Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis

Conditions: Osteoporosis
NCT01657162

Completed

Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis

Conditions: Postmenopausal Osteoporosis
NCT03005678

Completed

Denosumab Versus Bisphosphonates (Alendronate) in GIOP

Conditions: Osteoporosis
NCT01104987

Completed

Treatment With Alendronate in Patients With Ankylosing Spondylitis (AS)

Conditions: Ankylosing Spondylitis; Osteoporosis
NCT00010439

Completed

Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis

Conditions: Osteoporosis
NCT03051620

Completed

Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate

Conditions: Osteoporosis
NCT03435094

Recruiting

Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes

Conditions: Osteoporosis, Postmenopausal
NCT03980847

Completed

Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in the Preservation of the Tooth Socket

Conditions: Bone Resorption
NCT01512446

Terminated

Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy

Conditions: Osteoporosis
NCT02470611

Completed

Sodium Alendronate in Non Surgical Periodontal Therapy

Conditions: Periodontitis; Bone Resorption
NCT04403698

Recruiting

The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover

Conditions: Erosive Osteoarthritis
NCT00236002

Terminated

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

Conditions: Osteoporosis
NCT02781805

Terminated

Pilot Study of Bisphosphonates for Breast Cancer

Conditions: Breast Neoplasms
NCT02057263

Completed

The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults

Conditions: Hepatitis B
NCT00157690

Completed

Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients

Conditions: Cystic Fibrosis; Osteoporosis; Bone Diseases, Metabolic
NCT01889134

Completed

OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism

Conditions: Primary Hyperparathyroidism
NCT02230332

Completed

Alendronate to Prevent Loss of Bronchoprotection in Asthma

Conditions: Asthma